What is Generate Biomedicines, Inc. 's total revenue?

Generate Biomedicines, Inc. (GENB) reported total revenue of $7.22M in Q1 2026.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Generate Biomedicines, Inc. GENB Total Revenue

Total Revenue at other companies

MYR GroupMYRG

$1B+20.0%

SSR MiningSSRM

$581.78M+83.7%

Piper SandlerPIPR

$474.41M+32.8%

RepligenRGEN

$194.26M+14.8%

NNN REITNNN

$240.42M+4.1%

LKQLKQ

$3.47B+4.3%

Other financials

Income statement

See full

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's total revenue?: Generate Biomedicines, Inc. (GENB) reported total revenue of $7.22M in Q1 2026.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.